咆哮 发表于 2025-3-28 17:39:26
Anaphylaxis and Systemic Allergic Reactions,hylaxis is wheezing due to acute bronchospasm. Wheezing tends to occur particularly in patients with a history of asthma. Many of the symptoms of anaphylaxis are due to the effects of histamine, platelet-activating factor (PAF), and proteases on the cardiovascular, respiratory, and cutaneous systems单调性 发表于 2025-3-28 21:32:46
Aspirin or Nonsteroidal Drug-Exacerbated Respiratory Disease (AERD or NERD),gnosis of N-ERD is based on a medical history suggestive of the typical clinical manifestations, and in some patients, confirmation by an oral provocation test with aspirin can be performed when necessary. Treatment of N-ERD includes patient education for careful avoidance of COX-1 inhibitors, the u诱惑 发表于 2025-3-29 00:19:46
Asthma in Athletes,of the presence or severity of EIB. It is important to treat EIB in a similar manner as treating asthma. Optimal treatment should not just decrease daily symptoms of asthma, but significantly attenuate or even abolish EIB. To achieve this, the health-care provider must understand the prevalence, pat不能强迫我 发表于 2025-3-29 04:18:49
http://reply.papertrans.cn/16/1536/153506/153506_44.png沐浴 发表于 2025-3-29 09:30:45
Bronchodilator Therapy for Asthma,ort-acting beta-agonists (SABAs) are the most effective medications available in relieving bronchospasm and preventing exercise-induced bronchospasm. LABAs, when used in fixed combination with inhaled GCs, are very effective in improving asthma control and are the preferred controller agents for astCREST 发表于 2025-3-29 15:28:38
http://reply.papertrans.cn/16/1536/153506/153506_46.pngExaggerate 发表于 2025-3-29 18:07:08
Childhood Asthma,the absence of respiratory tract infections. In all age groups, current asthma management guidelines focus on a stepwise approach to symptom and risk control while addressing comorbidities and other modifiable risk factors such as inhaler technique, treatment adherence, and environmental exposures.APEX 发表于 2025-3-29 22:29:13
http://reply.papertrans.cn/16/1536/153506/153506_48.png放逐某人 发表于 2025-3-30 02:26:13
http://reply.papertrans.cn/16/1536/153506/153506_49.png导师 发表于 2025-3-30 07:26:57
http://reply.papertrans.cn/16/1536/153506/153506_50.png